Lodderomyces elongisporus endocarditis in an intravenous drug user: a new entity in fungal endocarditis

J Med Microbiol. 2012 Sep;61(Pt 9):1338-1340. doi: 10.1099/jmm.0.047548-0. Epub 2012 Jun 8.

Abstract

Lodderomyces elongisporus has been recently identified in the literature as an infrequent human bloodstream isolate, commonly mistaken for a non-albicans Candida. A case of Lodderomyces endocarditis in an intravenous drug user is described. To our knowledge, this report highlights the first documented case of Lodderomyces as a cause of endocarditis and summarizes the susceptibility patterns in the reported literature. All isolates reported so far have fluconazole MICs of ≤0.25 µg ml(-1).

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antifungal Agents / pharmacology
  • Azoles / pharmacology
  • Endocarditis / microbiology*
  • Humans
  • Male
  • Mycoses / microbiology*
  • Saccharomycetales / classification*
  • Saccharomycetales / drug effects
  • Saccharomycetales / genetics
  • Saccharomycetales / isolation & purification*
  • Substance Abuse, Intravenous / complications*

Substances

  • Antifungal Agents
  • Azoles